AGM Details
The 34th AGM was held on Tuesday, 8th September 2026 at 3:06 PM IST through Video Conferencing (VC)/Other Audio-Visual Means (OAVM). The meeting concluded at 3:18 PM IST on the same day. The deemed venue was the company's registered office in Ahmedabad, Gujarat.
Scrutinizer Appointment
Parmar Jitendra Pradipbhai, a Practising Company Secretary, was appointed as the Scrutinizer to conduct the remote e-voting and remote electronic voting during the AGM.
Voting Process and Timeline
- The cut-off date for determining shareholder eligibility to vote was Tuesday, 1st September 2026.
- Remote e-voting was conducted through the platform provided by National Securities Depository Limited (NSDL).
- Remote e-voting commenced at 9:00 AM on Saturday, 5th September 2026 and ended at 5:00 PM on Monday, 7th September 2026.
- Remote electronic voting during the AGM was available to shareholders present at the meeting who had not already voted, and this facility remained available until 15 minutes after the closure of the AGM.
- The final voting was locked and finalized on Wednesday, 9th September 2026 at approximately 11:37 AM IST.
Shareholder Communication
The notice of AGM was dispatched through email on Thursday, 13th August 2026 to members with registered email addresses. The notice was also placed on the company's website (www.hemoorganic.co), the NSDL e-voting website (www.evoting.nsdl.com), and the BSE website (www.bseindia.com).
Newspaper advertisements were published in Financial Express (English) and Financial Express (Gujarati) on 15th August 2026 regarding the date and time of commencement and end of remote e-voting.
Resolutions Voted On
Three ordinary resolutions were proposed for shareholder approval:
1. Adoption of the Annual Audited Financial Statements and Reports thereon
2. Appointment of Mr. Murlidhar Joshi (DIN: 09819849) as a director retiring by rotation
3. Appointment of M/s. V S S B & Associates, Chartered Accountants, as statutory auditors of the company
Voting Results
All three resolutions were passed unanimously with 100% votes in favor:
Resolution 1: Adoption of Financial Statements
- Total shares outstanding: 3,465,900
- Total votes polled: 590,655 (17.0419% of outstanding shares)
- Votes in favor: 590,655 (100% of votes polled)
- Votes against: 0
- Promoter & Promoter Group: 583,940 shares voted 100% in favor (100% participation)
- Public-Non Institutions: 6,715 shares voted 100% in favor (0.233% participation)
- Public-Institutions: 0 shares voted
Resolution 2: Appointment of Director
- Total shares outstanding: 3,465,900
- Total votes polled: 590,655 (17.0419% of outstanding shares)
- Votes in favor: 590,655 (100% of votes polled)
- Votes against: 0
- Promoter & Promoter Group: 583,940 shares voted 100% in favor (100% participation)
- Public-Non Institutions: 6,715 shares voted 100% in favor (0.233% participation)
- Public-Institutions: 0 shares voted
Resolution 3: Appointment of Auditors
- Total shares outstanding: 3,465,900
- Total votes polled: 590,655 (17.0419% of outstanding shares)
- Votes in favor: 590,655 (100% of votes polled)
- Votes against: 0
- Promoter & Promoter Group: 583,940 shares voted 100% in favor (100% participation)
- Public-Non Institutions: 6,715 shares voted 100% in favor (0.233% participation)
- Public-Institutions: 0 shares voted
Voting Participation Details
- Total of 9 members participated in the voting
- All voting was conducted through remote e-voting prior to the AGM (no voting during the AGM)
- No invalid votes were recorded across all shareholder categories
- No postal ballots were utilized
Document Certification
The report was digitally signed by Vishwambar Kameshwar Singh, Managing Director (DIN: 09822587) of Hemo Organic Limited, and countersigned by the Scrutinizer, Parmar Jitendra Pradipbhai (FRN No.: S2023GJ903900, COP No.: 15863, Membership No: F11336).